Lp-PLA2
Lp-PLA2 is a clinical biomarker on the Cardiometabolic panel, reported in nmol/min/mL. Standard reference range: 131–200 nmol/min/mL. Functional (optimal) range used by integrative practitioners: 150–190 nmol/min/mL.
What is Lp-PLA2?
Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an enzyme produced by macrophages in atherosclerotic plaques; elevated activity indicates active vascular inflammation and plaque vulnerability.
Reference ranges
| Range type | Value (nmol/min/mL) | Source |
|---|---|---|
| Standard (lab) | 131–200 | Typical Quest / LabCorp adult reference |
| Functional (optimal) | 150–190 | Integrative / functional medicine consensus |
How SomaVue interprets Lp-PLA2
SomaVue maps every result for Lp-PLA2 against four clinical lenses — nutrient cofactors, toxin exposure, infection drivers, and circadian/hormonal context — and connects each interpretation to specific peer-reviewed citations. Pre-mapped clinical reasoning and cross-marker pattern detection are available inside the practitioner workspace.
See the full interpretation
Upload a patient PDF or enter values manually to see the four-lens analysis, cross-marker patterns, and cited evidence for Lp-PLA2 and 205 other markers.
Try it freeEducational reference only. Reference ranges vary by laboratory, assay method, age, sex, and clinical context. Functional ranges represent integrative-medicine consensus and are not regulatory thresholds. SomaVue does not diagnose, treat, mitigate, or prevent disease. Always consult a licensed healthcare provider.